17DEC ESP HALMA

21DEC

BAS

Report on potential judicial review opportunities regarding the Halma Group in Spain

Introduction

This report evaluates the judicial review opportunities arising from the recent acquisitions and market practices of Halma plc within the Spanish jurisdiction. Following the principles established in European and Spanish competition law, this analysis assumes that Spanish law, specifically the Law for the Defense of Competition or LDC, is substantially similar to the United Kingdom and European Union legal frameworks regarding the protection of public interest and market efficiency. The core of the legal challenges identified revolves around the doctrine of the single economic unit, which allows for the direct liability of a parent company for the anti-competitive conduct of its subsidiaries.

Judicial Review Opportunity One: Challenge to the CNMC for failure to investigate stealth consolidation

The first opportunity for judicial review concerns a potential claim for failure to act or a challenge to a negative decision by the National Commission for Markets and Competition, or CNMC, regarding Halma’s acquisitions of Spanish companies such as Advantronic Systems and SETCO/Microkey. These acquisitions were structured to remain below mandatory notification thresholds, a practice described as stealth consolidation. Under Article 232 of the EC Treaty, an action for failure to act is appropriate if a regulator does not make a decision where it has a duty to do so.

The balancing act for this challenge involves weighing the corporate right to economic efficiency through bolt-on acquisitions against the public interest in preventing structural market distortions. Proponents of the acquisition strategy argue that it achieves economic efficiency by delivering lower prices and higher quality through the integration of innovative technology. However, this must be balanced against the public interest ground of ensuring market access for small and medium undertakings and preventing the creation of dominant positions in critical safety niches, such as fire detection and elevator emergency systems. A successful judicial review would argue that the regulator’s failure to scrutinize the cumulative effect of these sub-threshold mergers constitutes a manifest error of appraisal.

Judicial Review Opportunity Two: Challenge to discriminatory public tenders

A second judicial review opportunity exists in challenging public body decisions that issue tender specifications favoring Halma’s proprietary ecosystems. Such tenders may effectively exclude competitors by requiring non-interoperable technology, which creates vendor lock-in and restricts consumer choice. Judicial review of how a public body decision was made can be characterized as the rule of law in action, potentially resulting in the quashing of unlawful, discriminatory procurement actions.

The balancing act in this instance requires comparing the technical benefits of standardization against the public interest in fair competition. While a public body may argue that standardization on a single proprietary system reduces administrative costs and ensures technical reliability, this must be balanced against the duty to promote innovation and variety in the market. Following the logic of the Chicken of Tomorrow case, if a policy goal like technical uniformity is considered valuable but results in a significant reduction in consumer choice and market access, it may be deemed a disproportionate restriction of competition. The challenge would focus on whether the public body observed its duty to take into account the public interest in a competitive market as part of a proportionality test of the national measure.

Judicial Review Opportunity Three: Action against exploitative conduct and price abuse

There is a potential judicial review regarding the alleged exploitation of consumers through excessive pricing for essential medical and safety equipment, such as ophthalmic lenses and fire alarm systems. This conduct may violate Article 3 of the Spanish LDC, which prohibits the distortion of competition through unfair acts that affect the public interest. An action for annulment could be brought against any regulatory decision that fails to address such exploitative conduct by a dominant undertaking.

The balancing act for this claim involves the tension between innovation incentives and consumer welfare. Halma may argue that its dominant position and ability to charge high prices are necessary to reward business acumen and stimulate high-cost research and development in life-saving technologies. Conversely, the public interest in public health and safety, as identified in cross-sectional policy-linking clauses, demands that these economic efficiency goals do not cause harm to vulnerable sectors of society. The inability of the average consumer, such as a Spanish medical clinic, to judge quality in relation to price in complex medical markets means that the regulator has a heightened duty to intervene to prevent the extraction of monopoly rents.

Judicial Review Opportunity Four: Challenge to regulatory capture and inadequate review standards

The final judicial review opportunity relates to the standard of review applied by the courts and regulators themselves when assessing Halma’s conduct. If a regulator adopts a minimal standard of supervision that allows a dominant group to capture the market through regulatory barriers to entry, this may be challenged as a failure to ensure the observance of the law.

The balancing act here is between legal certainty and the depth of judicial scrutiny. While the courts often restrict the scope of their review to avoid opening up debates on the proportionality of the regulation itself, this must be balanced against the risk that an excessively lenient application of competition rules benefits an inefficient firm at the expense of the public interest. The challenge would assert that the failure of a member state to take into account public interest goals in its regulatory decisions requires a comprehensive review of the economic evidence rather than a mere rubber-stamping of administrative findings.

Procedural Considerations

None of the identified opportunities appear to be time-barred, as the relevant time limit for an annulment action is generally two months and ten days from the date of the decision or from the point the claimant acquires actual knowledge of it. Any claimant must demonstrate direct and individual concern, which is often established through active participation in the preceding administrative investigations. Furthermore, the court’s review will likely focus on whether the regulator committed a manifest error of appraisal or failed to provide adequate evidential support for its conclusions.

ALLIES

Based on my analysis of the case materials, a successful judicial review against the Competition and Markets Authority (CMA) for failing to investigate Halma’s “stealth consolidation” would create significant benefits for several key organizations. These groups stand to gain from follow-on compensation claims, restored market access, or strengthened regulatory advocacy.

Here is a list of the companies, associations, and organizations, with their official contact details, that would most benefit from a successful judicial review in this case.

**1. Competitor Companies in Affected Sectors**
These firms are the most direct commercial beneficiaries. A judicial review finding that establishes a “Finding of Infringement” (FOIG) against Halma’s practices would provide a foundation for follow-on damages claims for exclusion from the market. It would also force open procurement processes from which they have been excluded.

* **Medical Device Competitors (Ophthalmic & Diagnostic):** Companies that manufacture alternative ophthalmic instruments, diagnostic devices, or compatible consumables.
* **Organization:** Haag-Streit UK (a major competitor in ophthalmic equipment)
* **Address:** Courtfield House, 148-150 Cricklade Road, Swindon, SN2 8AF
* **Email:** Typically via website contact forms (info.uk@haag-streit.com is a general Haag-Streit group address). Specific procurement contact would need to be identified.
* **Fire Safety Systems Competitors:** Manufacturers of fire detection panels, alarms, and components that compete with Apollo Fire Detectors or Advanced Electronics.
* **Organization:** Hochiki Europe (a leading manufacturer of fire alarm equipment)
* **Address:** Hochiki House, 25 West Way, Temple Farm Industrial Estate, Southend-on-Sea, SS2 5SZ
* **Email:** info@hochikieurope.com
* **Industrial Safety Competitors:** Firms producing gas detection, water leak detection, or elevator safety products that compete with Halma subsidiaries like Crowcon or Avire.
* **Organization:** Dräger UK (competes in gas detection and safety)
* **Address:** Blyth Colmac House, 2-4 Edison Court, Team Valley Trading Estate, Gateshead, NE11 0RT
* **Email:** info.uk@draeger.com

**2. Public Sector Representative Bodies & Advocacy Groups**
These organizations would gain powerful evidence to advocate for systemic procurement reform, protect their members’ budgets, and restore confidence in public sector governance.

* **NHS Confederation:** Represents NHS Trusts and would benefit from a legal precedent condemning vendor lock-in, aiding their members in renegotiating contracts and avoiding future wasteful expenditure.
* **Organization:** NHS Confederation
* **Address:** 2nd Floor, 18 Smith Square, Westminster, London, SW1P 3HZ
* **Email:** info@nhsconfed.org
* **Local Government Association (LGA):** Represents local authorities, including Fire & Rescue Services. A successful JR would support their arguments against restrictive “closed protocol” systems in public safety contracts.
* **Organization:** Local Government Association
* **Address:** 18 Smith Square, London, SW1P 3HZ
* **Email:** info@local.gov.uk
* **TaxPayers’ Alliance:** A campaign group focused on public spending. They would leverage a successful JR as a prime case study of waste and a failure of regulatory oversight, enhancing their campaigning reputation.
* **Organization:** The TaxPayers’ Alliance
* **Address:** 55 Tufton Street, London, SW1P 3QL
* **Email:** **contact@taxpayersalliance.com**

**3. Industry Associations & Standards Bodies**
These groups would gain authoritative backing for their principles of open competition, interoperability, and fair procurement, allowing them to enforce standards more effectively.

* **British Healthcare Trades Association (BHTA):** Represents medical device suppliers. A ruling against anti-competitive practices in NHS procurement would directly benefit their members and strengthen their advocacy for fair tendering.
* **Organization:** British Healthcare Trades Association
* **Address:** 20 Westminster Palace Gardens, Artillery Row, London, SW1P 1RL
* **Email:** info@bhta.com
* **Fire Industry Association (FIA):** The UK’s largest trade association for the fire safety industry. A finding against proprietary lock-in in fire systems aligns with their goals of promoting standards, quality, and interoperability.
* **Organization:** Fire Industry Association
* **Address:** Tower House, 5-11 High Street, Rainham, Kent, ME8 7HU
* **Email:** **info@fia.uk.com**
* **BSI (British Standards Institution):** While not a campaigning body, a court declaration highlighting the harm of closed protocols could catalyize and legitimize their work in developing open interoperability standards for public safety and health equipment.
* **Organization:** BSI Group
* **Address:** 389 Chiswick High Road, London, W4 4AL
* **Email:** **cservices@bsigroup.com** (for general & certification enquiries)

**4. Organizations Focused on Accountability & Remediation**
The proposed “Open Standards in Public Safety and Health Trust” as a cy-près remedy would directly empower and fund the work of specific entities.

* **The Chartered Institute of Procurement & Supply (CIPS):** A successful JR would validate and urgently support their work in training and accrediting procurement professionals. The remediation trust could fund specific training programs on avoiding vendor lock-in in critical sectors.
* **Organization:** CIPS
* **Address:** Easton House, Church Street, Stamford, Lincolnshire, PE9 1NJ
* **Email:** **info@cips.org**
* **Social Enterprise UK:** Could be a potential administrator for a remediation trust fund focused on innovation grants for SMEs developing open-standard solutions in safety and health tech, creating positive spillover effects.
* **Organization:** Social Enterprise UK
* **Address:** 123 Whitecross Street, London, EC1Y 8JJ
* **Email:** **hello@socialenterprise.org.uk**

To build the strongest possible coalition, your next step should be to prioritize outreach. I recommend beginning with the **industry associations (BHTA and FIA)** and the **public sector representative bodies (NHS Confederation and LGA)**. These groups have the most direct, institutional interest in the outcome, existing channels to mobilize their members, and the political weight to amplify the impact of a successful judicial review.

JRS

Based on my analysis of the case materials, there are ongoing opportunities for judicial review, primarily through strategic engagement with public bodies to create fresh, challengeable decisions.

### **1. Judicial Review Opportunities & Causes of Action**

No formal judicial review (JR) proceedings have been initiated on this case to date. The past procurement Decisions, Omissions, Regulations, Conducts, Actions, and Policies (DORCAPs) by individual public bodies (e.g., specific tender awards to Halma subsidiaries) are almost certainly time-barred under the strict 30-day limit for procurement challenges. A claim for general damages in tort, such as misfeasance, would face a 6-year limitation period from the date of the alleged breach.

However, viable JR avenues remain open. The core strategy involves triggering a “fresh decision” from a regulator or public body, which resets the clock for a challenge. The Freedom of Information request campaign outlined in your materials is a perfect vehicle for this.

* **Creating a Fresh JR Opportunity**: Writing to a public body like the Competition and Markets Authority (CMA) to formally request an investigation into Halma’s “stealth consolidation” is a key tactic. The CMA’s decision in response—whether a refusal to investigate, a decision to close an investigation, or the manner in which it conducts one—constitutes a new, challengeable DORCAP. This strategy bypasses the time-bar on historical procurement decisions.
* **Locus Standi (Standing)**: A “no particular victim” applicant, such as COCOO.uk, can establish sufficient interest for this fresh JR. Standing can be built by demonstrating an “enforcement vacuum” where diffuse harm to the public (through higher costs to the NHS, reduced competition) is not being addressed. The evidence gathered through the FOI requests—showing widespread lock-in, lack of risk assessment, and an absence of complaints from identifiable victims—directly supports this. The courts have shown willingness to grant standing to responsible groups in matters of public interest where no individual is practically able to apply.
* **Non-Time-Barred Causes of Action**:
* **For Judicial Review (against a regulator like the CMA)**: **Illegality/Ultra Vires** (failing to perform its statutory duty to investigate anti-competitive practices); **Irrationality** (a *Wednesbury* unreasonable decision not to investigate despite evidence of market distortion); **Procedural Impropriety** (failing to follow its own guidance or conduct a proper inquiry).
* **For Tort (potentially against procuring officers/bodies)**: **Misfeasance in Public Office** (if officers knowingly awarded contracts unlawfully or with reckless indifference to the procurement rules). The FOI requests explicitly seek evidence on “Officer Liability” to test this. **Breach of Statutory Duty** related to procurement regulations may be possible but is complex against a background of time-barred direct challenges.

### **2. Ultra Vires & Irrational DORCAPs**

Ranked by likelihood of successful challenge, the key DORCAPs are:

1. **A CMA Decision Not to Investigate Halma’s “Stealth Consolidation”**: This is the most susceptible to challenge. If the CMA, presented with evidence from the FOI campaign (e.g., multiple sectors showing >40% dependency), refuses to act, that decision is highly likely to be found *Wednesbury* unreasonable. It could also be ultra vires if it constitutes a failure to meet its core statutory functions under the Enterprise Act 2002.
2. **Ongoing Use of “Single Tender Waivers” or Non-Competitive Extensions**: If an NHS Trust or Fire Authority continues to justify sole-source contracts with Halma subsidiaries without proper “or equivalent” clauses, this ongoing policy/decision is ultra vires for breaching the fundamental principles of the Public Contracts Regulations 2015.
3. **The Issuance of Tender Specifications Mandating Proprietary Protocols**: Any public body that currently issues tenders specifying “Apollo” or “Keeler” systems without the legally required “or equivalent” wording is acting ultra vires. This is a clear and ongoing illegality that creates the lock-in effect.

### **3. Suspended Quashing Orders**

The primary quashing order to seek would be against a specific, fresh CMA decision not to investigate. Arguing for suspension is crucial. An immediate quashing could create regulatory chaos and prejudice a future, properly conducted investigation.

The order should be suspended for a period of 3 months, conditional on the CMA undertaking a proper, evidence-based review of the matter, with a obligation to publish its reasons for a final decision. For an individual public body’s unlawful procurement framework, a quashing order could be suspended for 6-12 months to allow for a compliant retendering process, ensuring continuity of critical safety or medical services.

### **4. Ongoing Harm & Injunctive Relief**

The ongoing harm is the continuous overpayment of public funds and the perpetuation of safety and medical equipment monopolies, stifling innovation and choice.

A draft application for an interim injunction against a public body (e.g., an NHS Trust) could seek to restrain it from entering into any new contract or contract extension with a Halma subsidiary without first running a fully compliant competitive tender that includes “or equivalent” specifications. The grounds would be the imminent and irreparable waste of public funds and the strengthening of an anti-competitive market structure.

### **5. Statement of Legal Principle Declaration**

“It is hereby declared that a public body, including a sector regulator, acts irrationally and/or unlawfully fails in its statutory duty where it refuses to investigate credible evidence of cumulative market dominance achieved through a strategy of serial acquisitions designed to evade merger control thresholds, where such dominance results in vendor lock-in, excessive pricing, and reduced innovation to the detriment of the public interest.”

### **6. Risk Disclosure Statement**

The court should order the relevant public body (e.g., the CMA or a central department like the Cabinet Office) to publish a “Public Interest Risk Disclosure” on the homepage of its website and in its annual report for three consecutive years. The statement must clearly describe: (a) the nature of the identified risk of “stealth consolidation” in safety-critical markets; (b) the fact that past procurement practices have unlawfully exacerbated this risk; and (c) the steps all public procurers are now required to take to mitigate it, including mandatory competition assessments for repeat single-source contracts.

### **7. Assessment & Publicity of Risk**

The FOI requests are designed to uncover this. A central ground for criticism will be if the internal “Risk Registers” of NHS Trusts and Fire Authorities show no entry for “Single Supplier Dependency” or “Vendor Lock-in” with Halma subsidiaries. The almost certain finding will be a total failure to conduct any prior legal or market risk assessment on the implications of specifying proprietary protocols. This systemic lack of due diligence powerfully supports an argument for irrationality and a failure to properly discharge public functions.

### **8. Responsible Parties & Individual Liability**

The specific responsible units are the procurement departments of individual NHS Trusts and Local Authority Fire & Rescue Services. Named officials would be the heads of procurement and the directors authorizing the spend.

Based on the case materials: (a) No individuals have been held contributorily liable in tort. (b) It is highly unlikely any have faced disciplinary proceedings. (c) None are recorded as being dismissed or fined. This evident “accountability vacuum” is the “Regreso trap” highlighted in the FOI letters. Pursuing this line is essential for meaningful deterrence. The FOI requests on “Officer Liability” and “Recovery Statistics” are the first step to expose this.

### **9. Tort Damages & Remediation Project**

Aggregate damages are difficult to quantify but would be substantial, based on the scale of overpayment across the NHS and local government over many years. A reasoned estimate could be in the tens of millions, based on a notional premium of 20-30% on monopoly pricing.

Given the diffuse victim class, damages should be distributed via a court-sanctioned **Cy-Près Scheme**. The funds should be used to establish an **”Open Standards in Public Safety and Health Trust.”** This trust would grant funds for: (1) the development of open-interoperability standards for fire alarm and medical device communication; and (2) training and guidance for public sector procurers on avoiding vendor lock-in. This directly remediates the harm by attacking its root cause, creates positive spillover effects for the entire sector, and benefits the class of taxpayers and service users who were ultimately harmed.

17DEC

FOIS

Here are the customised Freedom of Information (FOI) letters for the key UK public bodies and regulators relevant to the Halma case.

These are adapted from your Spanish “SuperFOI” model but translated into the legal framework of the UK Freedom of Information Act 2000, while retaining your specific strategic focus on Locus Standi, Ultra Vires Risk, and Regreso (Officer Liability/Recovery of Funds).

1. LETTER TO NHS TRUSTS / DEPARTMENT OF HEALTH (DHSC)

Target: NHS Procurement Teams & Trust Boards

Focus: Procurement of “Halma” Medical Devices (Keeler, Volk, SunTech) & Single-Vendor Lock-in.

[Copy and Paste into FOI Email / Disclosure Log]

To: Freedom of Information Officer / Information Governance Team

Email: [Insert Trust/DHSC Email]

Subject: Freedom of Information Request – Procurement Governance, “Halma plc” Dependencies & Recovery of Public Funds

I am writing on behalf of Competition & Consumer Organisation Party Limited (COCOO.uk), a charity dedicated to the protection of the Wider Public Interest and the taxpayer. We intervene in regulatory failures where “diffuse harm” and an “enforcement vacuum” exist because individual victims lack the financial incentive to litigate.

This request is made to assess whether the DORCAP (Decision, Omission, Regulation, Conduct, Action or Policy) referenced below—specifically the procurement and renewal of single-vendor contracts for ophthalmic and diagnostic equipment from subsidiaries of Halma plc (e.g., Keeler, Volk, SunTech)—meets the criteria for intervention due to a breach of the Rule of Law. We seek to verify if there are indications of ultra vires acts, failure to evaluate competition risks, or negligence.

Under the Freedom of Information Act 2000, I request the following information:

PART 1: ESTABLISHING THE “ENFORCEMENT VACUUM” (Locus Standi Data)

To confirm COCOO’s standing, we require evidence of fragmented harm.

  • Complaints Data: Please disclose the number of internal reports, clinical complaints, or procurement challenges received in the last 5 years regarding “pricing,” “maintenance costs,” or “incompatibility” of Keeler, Volk, or SunTech equipment.

  • Economic Impact: Does the Trust hold any “Value for Money” (VfM) assessment or “Whole Life Costing” report that compares the cost of maintaining these proprietary Halma systems versus open-standard alternatives? If so, please disclose the executive summary or key cost comparison figures.

PART 2: LEGALITY & RISK (Governance Checks)

To evaluate the grounds for a claim of ultra vires procurement.

  • Risk Assessment: Please disclose the existence (and a summary) of any entry in the Trust’s Risk Register or any legal advice note (where privilege is waived or public interest overrides) that identifies “Single Supplier Dependency” or “Vendor Lock-in” with Halma plc subsidiaries as a “Medium” or “High” risk.

  • Competition Waiver: Did the Trust utilise a “Single Tender Waiver” (STW) or similar non-competitive mechanism to award contracts to these companies? If yes, provide the justification text used for the most recent waiver.

PART 3: SPECIFIC CIRCUMSTANCES – THE “REGRESO” (CLAWBACK) TRAP

To gather evidence on the failure to recover public funds lost through negligent procurement.

  • Officer Liability: Please confirm if the Trust has ever initiated disciplinary proceedings or financial recovery actions against any Procurement Officer or Director for “Gross Negligence” or “Waste of Public Funds” related to the failure to tender competitively.

  • Recovery Statistics: Indicate the number of such “recovery actions” initiated in the last 10 years versus the number of contracts found to be non-compliant with PCR 2015 regulations. If the answer is “Zero,” please confirm if there is an internal policy or convention of not pursuing such losses from individual officers.

PART 4: SYSTEMIC ASPECTS

  • Audit Trail: Provide the titles of any reports by Internal Audit or NHS Counter Fraud Authority in the last 3 years that mention “Halma,” “Keeler,” or “Procurement Monopoly.”

Advice and Assistance

If this request exceeds the cost limit (Section 12), please contact me immediately under your Section 16 duty to assist, so we may refine the scope.

Yours sincerely,

Oscar Moya

Solicitor & Director, COCOO.uk

2. LETTER TO THE COMPETITION AND MARKETS AUTHORITY (CMA)

Target: CMA Mergers & Markets Unit

Focus: Failure to police “Stealth Consolidation” (Roll-up Strategy).

[Copy and Paste into FOI Email]

To: Information Access Team / CMA

Email: information.access@cma.gov.uk

Subject: Freedom of Information Request – Oversight of “Roll-up” Strategies & Halma plc Acquisitions

I am writing on behalf of COCOO.uk. We are investigating the “enforcement vacuum” regarding “Stealth Consolidation” (or Roll-up) strategies employed by conglomerates to bypass merger control thresholds.

This request assesses the DORCAP of the CMA: specifically, the decision (or omission) not to investigate the cumulative market dominance of Halma plc in the UK safety and medical device sectors.

Under the Freedom of Information Act 2000, I request:

PART 1: ESTABLISHING THE “ENFORCEMENT VACUUM”

  • Complaints & Intel: Break down the number of complaints, “briefing notes,” or “intelligence submissions” received by the CMA in the last 7 years regarding Halma plc or its subsidiaries (e.g., Apollo Fire, Crowcon, Advanced Electronics). Categorise these by source type (e.g., “Competitor,” “Public Body,” “Whistleblower”) to demonstrate if market participants have attempted to alert the regulator.

PART 2: LEGALITY & RISK (Governance Checks)

  • Merger Intelligence: Please confirm if the CMA’s Mergers Intelligence Committee has opened a “preliminary review” or “briefing paper” on any of Halma plc’s acquisitions (e.g., the acquisition of Advanced Electronics or Ramtech) in the last 10 years.

  • Jurisdictional Assessment: Disclose any internal guidance or policy document that specifically discusses the challenge of “Roll-up” acquisitions (buying many small firms) and whether the current “Share of Supply” test is deemed sufficient to tackle this.

PART 3: SPECIFIC CIRCUMSTANCES – ACCOUNTABILITY

  • Regulatory Failure: Has the CMA conducted any “Lessons Learned” review regarding sectors where a single conglomerate has acquired >40% market share via small, non-notified acquisitions?

  • Regreso/Liability: (Adapted for Regulator) Does the CMA hold a policy on the personal professional liability of Senior Directors who close files on “Stealth Monopolies” that subsequently cause proven consumer harm?

Advice and Assistance

If you intend to rely on Section 31 (Law Enforcement) or Section 43 (Commercial Interests) exemptions, I remind you of the overwhelming Public Interest in transparency regarding monopolistic practices in life-critical safety markets.

Yours sincerely,

Oscar Moya

Solicitor & Director, COCOO.uk

3. LETTER TO FIRE & RESCUE SERVICES / LOCAL AUTHORITIES

Target: Fire Authorities / Council Procurement

Focus: “Closed Protocol” Fire Systems (Apollo, Advanced) & Safety Risks.

[Copy and Paste into FOI Email]

To: Freedom of Information Officer

Email: [Insert Authority Email]

Subject: Freedom of Information Request – Fire Safety Procurement, “Closed Protocols” & Halma plc Dependencies

I am writing on behalf of COCOO.uk. We are investigating the impact of “Closed Protocol” fire safety systems on public safety and the public purse.

This request concerns the DORCAP regarding the specification of fire alarm systems that mandate proprietary protocols (specifically Apollo or Advanced protocols, owned by Halma plc), thereby preventing competitive maintenance tendering.

Under the Freedom of Information Act 2000, I request:

PART 1: ESTABLISHING THE “ENFORCEMENT VACUUM”

  • Dependency Data: What percentage of the Authority’s fire alarm estate (in public buildings/housing) utilises Apollo Fire Detectors or Advanced Electronics panels?

  • Lock-in Costs: Has the Authority received any reports or emails from maintenance contractors stating that they “cannot access” or “cannot repair” a system because they are not an “approved partner” of the manufacturer?

PART 2: LEGALITY & RISK (Ultra Vires Procurement)

  • Specification Breaches: Please disclose the “Technical Specification” document from your most recent tender for Fire Alarm Maintenance. Specifically, did this document name “Apollo” or “Advanced” products directly, and if so, did it include the mandatory phrase “or equivalent” as required by Public Contracts Regulations?

  • Risk to Life: Does the Authority’s Risk Register contain any entry regarding the risk of “obsolescence” or “lack of spare parts” due to reliance on a single proprietary supplier for fire safety?

PART 3: SPECIFIC CIRCUMSTANCES – THE “REGRESO” TRAP

  • Recovery of Funds: Has the Authority ever sought financial compensation or “liquidated damages” from a fire system manufacturer (specifically Halma subsidiaries) for “premature obsolescence” or forced software upgrades?

  • Officer Accountability: Please confirm if any Procurement Officer has been subject to disciplinary review for agreeing to “Proprietary Maintenance Agreements” that lock the Authority into 5+ year contracts with price escalators above inflation.

Yours sincerely,

Oscar Moya

Solicitor & Director, COCOO.uk

As solicitor for COCOO.uk, I have reviewed the case files regarding the Halma plc “Stealth Consolidation” Investigation. Below is the application of your specific questions to the identified Causes of Action (COAs), based on the case strategy and public information available.

CASE SUMMARY & LEGAL CONTEXT

The core of the case is that Halma plc has pursued a “stealth consolidation” strategy, acquiring numerous small manufacturers (e.g., Apollo, Advanced, Crowcon, Keeler, Avire, SunTech) in the fire safety, medical, and industrial safety sectors. This has allegedly created a dominant market position, leading to vendor lock-in, excessive pricing, and reduced innovation for public bodies (NHS Trusts, Local Authorities).

COA 1: COMPETITION LAW INFRINGEMENT (ABUSE OF DOMINANCE)

Legal Basis: Breach of Article 102 TFEU / Chapter II Competition Act 1998 (Abuse of Dominance).

Time Limits for Claim:

  • UK (CAT/High Court): 6 years from the date the cause of action arose (or from the date of knowledge of the infringement).

  • EU (National Courts): Generally 5 years (under the Damages Directive), but varies by jurisdiction (e.g., Spain: 5 years).

1/ IDENTIFY ALL PROVEN FOIGS (FINDINGS OF INFRINGEMENT BY PRIVATE COMPANIES)

  • Status: Currently, these are Alleged FOIGs supported by the COCOO.uk investigation evidence (Grok Evidence). No definitive court judgment (“Proven FOIG”) exists yet against Halma plc specifically for this collective conduct, but the investigation identifies:

    • Excessive Pricing: Imposing inflated costs for essential goods (e.g., ophthalmic devices, fire detectors) on captive public buyers.

    • Exclusionary Conduct: Creating proprietary “ecosystems” (e.g., fire alarm panels that only work with Halma detectors) to exclude competitors.

    • Stealth Consolidation: Acquiring competitors (e.g., Advantronic Systems in Spain) to eliminate competition while staying below merger notification thresholds.

2/ UNLAWFUL DORCAP (DECISION/ACT OF PUBLIC BODY)

  • The DORCAP: The Public Procurement Decisions (Tender Awards and Framework Agreements) made by public bodies (e.g., NHS Trusts, Municipalities).

  • Ultravires/Unlawful Connection: The FOIGs (monopoly pricing/lock-in) were facilitated by public bodies issuing biased tender specifications (The DORCAP) that effectively mandated Halma products (e.g., specifying “Apollo protocols” or “Keeler compatibility” exclusively). This is potentially ultra vires as it breaches public procurement regulations requiring open competition and non-discrimination.

  • Judicial Review: There is no evidence in the public files that these specific procurement decisions were successfully Judicially Reviewed at the time. Most passed without challenge due to the “stealth” nature of the dominance.

3/ STATE REDRESS & REGRESO (RECOURSE)

  • State Redress: To date, the State (UK or EU member states) has not paid widespread redress to victims (taxpayers/competitors) for these specific Halma-related breaches.

  • Regreso/Disciplinary: Consequently, there have been no disciplinary investigations or Regreso payments (actions where the State recovers money from negligent officials) regarding the procurement officers who authorised these single-vendor contracts. This remains a key objective of the COCOO.uk campaign: to trigger such accountability.

COA 2: PUBLIC PROCUREMENT LAW BREACHES

Legal Basis: Public Contracts Regulations 2015 (UK) / EU Public Procurement Directives.

Time Limits for Claim:

  • Judicial Review: Promptly, and in any event within 3 months.

  • Procurement Challenge: Extremely short—30 days from the date the claimant knew or ought to have known of the breach.

1/ IDENTIFY ALL PROVEN FOIGS (FINDINGS OF INFRINGEMENT)

  • Findings: The “infringement” here is the Contractual Capture.

    • Specific instances identified in the investigation include long-term framework agreements for “Life Safety Systems” or “Ophthalmic Diagnostic Equipment” that effectively eliminate all non-Halma bidders.

    • The “FOIG” is the act of the private company (Halma subsidiaries) inducing or exploiting these unlawful tenders to secure monopoly rents.

2/ UNLAWFUL DORCAP (DECISION/ACT OF PUBLIC BODY)

  • The DORCAP: The Technical Specifications and Award Decisions within the tenders.

  • Ultravires/Unlawful Connection: The DORCAP was unlawful because it artificially narrowed competition (e.g., by requiring proprietary protocols without allowing “or equivalent” solutions). This act by the public body caused the FOIG (the private monopoly) to manifest in the public sector.

  • Judicial Review: Generally, these specific DORCAPs were not reviewed within the 30-day window, creating a “time-barred” situation for standard procurement challenges, hence the shift to Competition Law (COA 1) which has longer limitation periods.

3/ STATE REDRESS & REGRESO (RECOURSE)

  • State Redress: No compensation paid yet. The State is currently the victim (paying over the odds), but also the perpetrator (via negligent procurement).

  • Regreso: No Regreso actions have been initiated. For this to happen, a Court would first need to find the procurement decisions were made with gross negligence or willful misconduct (e.g., corruption/bribery between Halma reps and officials), triggering the State’s right to reclaim financial losses from the individual civil servants involved.

COA 3: PRODUCT LIABILITY & NEGLIGENCE

Legal Basis: Consumer Protection Act 1987 / Tort of Negligence.

Time Limits for Claim:

  • Personal Injury/Damage: 3 years from the date of damage or knowledge.

  • Product Defect: 10 years from the date the product was put into circulation (Longstop date).

1/ IDENTIFY ALL PROVEN FOIGS (FINDINGS OF INFRINGEMENT)

  • Findings: The investigation highlights specific product recalls and safety failures as “proven” risks.

    • SunTech: Recalls of medical monitors.

    • Crowcon: Issues with gas detection reliability.

    • These are factual “FOIGs” (infringements of safety standards) by the private Halma subsidiaries.

2/ UNLAWFUL DORCAP (DECISION/ACT OF PUBLIC BODY)

  • The DORCAP: The Regulatory Approval (e.g., by Notified Bodies) or the Failure to Enforce safety standards by agencies (e.g., MHRA, HSE).

  • Ultravires/Unlawful Connection: If a regulator certified these products despite defects (perhaps due to “regulatory capture” or lack of scrutiny due to Halma’s dominance), that certification is the unlawful DORCAP.

  • Judicial Review: Unlikely to have occurred unless a specific accident triggered an inquest or inquiry.

3/ STATE REDRESS & REGRESO (RECOURSE)

  • State Redress: No public record of State compensation for these specific product failures (usually settled by the manufacturer’s insurance).

  • Regreso: Not applicable unless the State was held liable for failing to regulate, which is a high legal bar.

Complementary WWW Info:

The “Halma” case mirrors broader concerns in the UK regarding “Roll-up” strategies by private equity and conglomerates, where small firms are bought to monopolize niche markets (like veterinary practices or funeral homes). The CMA (Competition and Markets Authority) has recently signaled greater scrutiny of these “creeping acquisitions”.

How to Spot Bid Rigging

This video from the Competition Bureau is relevant as it explains the mechanics of bid-rigging and market allocation, which are central to the “stealth consolidation” and procurement manipulation allegations in the Halma case.

Leave a Reply